Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease

NCT: NCT07223164 · COMPLETED

NCT IDNCT07223164
StatusCOMPLETED
Start Date2025-10-21
Completion2025-10-31
SponsorMasimo Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

Specificity measure of performance of the Irregular Heartbeat Detection algorithm (evaluated for the finger and wrist form factors) against the Masimo Radius VSM® reference ECG. Each form factor will be evaluated independently of one another

Frequently Asked Questions

What is Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease?

Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease is a clinical trial registered under NCT07223164. Current status: COMPLETED.

What is the status of NCT07223164?

The current status of NCT07223164 (Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease) is: COMPLETED.

When did Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease start?

Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease started on 2025-10-21.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.